Elagolix is a medicine used to ease moderate to severe pain from endometriosis. It is taken as a pill by mouth. It works by lowering the body's estrogen, which helps calm the tissue that causes the pain.
Every report comes from a Lived member, sent anonymously.
Have you tried Orilissa (Elagolix) for Endometriosis?
Elagolix, sold under the brand name Orilissa, is a prescription pill for moderate to severe pain caused by endometriosis. Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it, often on the ovaries or other pelvic organs, causing painful periods, pelvic pain between periods and pain during sex. Elagolix is approved for premenopausal adults and is meant to ease that pain for a limited time, because of its effect on bone. It belongs to a group of medicines called GnRH antagonists. A related product, Oriahnn, combines elagolix with low doses of the hormones estradiol and norethindrone acetate and is approved for a different problem: heavy menstrual bleeding from uterine fibroids. The two are separate prescriptions and are not swapped for one another.
The brain controls the ovaries through a chain of hormones. Gonadotropin-releasing hormone (GnRH) signals the pituitary gland to release two hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn tell the ovaries to make estrogen and progesterone. Elagolix blocks the pituitary's GnRH receptors, so less LH and FSH are released and the ovaries make less estrogen. Endometriosis is driven by estrogen, so lowering estrogen tends to quiet the misplaced tissue and the pain it causes. The effect depends on the dose. The lower dose reduces estrogen partway, and ovulation still happened in about half of cycles in one study, while the higher dose lowers estrogen much further. The same drop in estrogen explains the medicine's main side effects, such as hot flashes and bone thinning, and it is why elagolix cannot be counted on as birth control.
Orilissa is a tablet taken by mouth at about the same time each day, with or without food. There are two regimens. The usual starting dose is 150 mg once a day, which can be used for up to 24 months. A higher dose of 200 mg twice a day may be considered when pain during sex is a major problem, but it is limited to 6 months because it causes more bone loss. People with moderate liver disease take only the lower dose, for no more than 6 months. Before the first dose, pregnancy is ruled out, or treatment is started within 7 days after a period begins. If a dose is missed, take it later the same day once you remember, then continue the usual schedule. Do not take more than one tablet a day on the once-daily dose, or more than two a day on the twice-daily dose. Your clinician may suggest calcium and vitamin D supplements while you take it.
Hot flashes and night sweats are the most common side effect, reported by about a quarter of people on the lower dose and nearly half on the higher dose. Headache, nausea, trouble sleeping, joint pain and lighter or missed periods are also common. Most side effects are more frequent at the higher dose, and most people who stopped early because of hot flashes or nausea did so in the first two months. Cholesterol and triglyceride levels can rise. Elagolix thins bone. Bone density falls more with the higher dose and with longer use, and it may not fully recover after stopping. This is the main reason treatment is time-limited. Mood changes need attention. In studies, people taking elagolix had more depression and mood changes than people on placebo, especially those with a past history of depression, and suicidal thoughts and behavior occurred. Tell your prescriber promptly about new or worsening depression, anxiety or other mood changes, and get immediate medical help for thoughts of suicide or self-harm. Liver test results can also rise; contact your care team promptly if your skin or the whites of your eyes turn yellow. Rarely, serious allergic reactions have occurred; swelling of the face, lips or throat or trouble breathing needs emergency care.
Elagolix is not used during pregnancy, because it may raise the risk of early pregnancy loss. Use effective non-hormonal contraception, such as condoms or a copper intrauterine device (IUD), during treatment and for 28 days after the last dose. Hormonal birth control is not a good fit: estrogen-containing methods can make elagolix less effective, and taking them with the higher dose raises estrogen-related risks such as blood clots, while elagolix can make some progestin-containing pills less effective. Because elagolix often makes periods lighter or stops them, a pregnancy can be easy to miss. Take a pregnancy test if pregnancy is possible, and stop the medicine if it is confirmed. Elagolix is not used by people with known osteoporosis (weak, fragile bones) or severe liver disease, or by people who take cyclosporine, a transplant and immune-suppressing medicine, or gemfibrozil, a cholesterol medicine, which can raise elagolix to unsafe levels. People with a past low-impact fracture or other risk factors for bone loss may need a bone density scan first. Elagolix also affects how the body handles several other medicines, including digoxin (a heart medicine) and rosuvastatin (a statin), and some antibiotics, antifungals and seizure medicines can change its level. Give your prescriber and pharmacist a full list of medicines and supplements. There is no information on elagolix in breast milk, so discuss it before using it while breastfeeding.
In the main studies, people taking elagolix were more likely than those on placebo to have a meaningful drop in period pain and pelvic pain by three months, with a larger effect on period pain and at the higher dose. Many people also improved on placebo, and not everyone responds, so your clinician will judge whether the benefit is worth the side effects. Periods often become lighter, irregular or stop altogether while taking it. Follow-up visits check pain, mood and side effects, and may include liver tests or a bone density scan. Because of bone loss, treatment ends at 6 or 24 months depending on the dose. Elagolix eases pain but does not remove endometriosis tissue, so symptoms may come back, and planning what comes next, whether another medicine, surgery or a different approach, is part of the conversation from the start.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Orilissa (Elagolix), what you've noticed, or ask the community a question.